On December 5, 2018 Transgene (Paris:TNG) reported that Management will participate in the upcoming investor events set out below (Press release, Transgene, DEC 5, 2018, View Source [SID1234531915]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Transgene will meet institutional investors at the LifeSci Advisors Corporate Access Event from January 7 to 9, 2019, in San Francisco, USA, concurrent with the J.P. Morgan Healthcare conference.

The Company will also attend:

Oddo Forum: January 10 & 11, 2019 – Lyon, France
Biomed Event: January 22, 2019 – Paris, France
Degroof Petercam Healthcare Seminar: January 31, 2019 – Brussels, Belgium
HC Wainwright Conference: April 8 & 9, 2019 – London, UK
Kempen Life Sciences Conference: April 16 & 17, 2019 – Amsterdam, Netherlands
Small Cap Event: April 16 & 17, 2019 – Paris, France